Phil Grayeski

Phil Grayeski is the Managing Partner at KdT Ventures, an early-stage venture capital firm focused on frontier science and technology investments. In this executive role, he directs capital allocation across a diverse portfolio of emerging companies that are actively commercializing complex advancements in biology, chemistry, physics, and computational sciences. Grayeski is recognized as a prominent figure in early-stage biotech entrepreneurship and previously served as an industry judge at the 2020 Venture Capital Investment Competition (VCIC) hosted by the University of North Carolina (UNC). He evaluates novel scientific platforms and provides strategic guidance for startups operating at the intersection of deep technology and life sciences, helping founders navigate the transition from laboratory research to market application. Grayeski currently focuses on identifying and scaling foundational scientific breakthroughs into commercially viable enterprises within the broader biotechnology and frontier technology sectors.